Skip to main content

Year: 2023

Nexus Industrial REIT Announces Q3 2023 Results and December Distribution

TORONTO, Nov. 14, 2023 (GLOBE NEWSWIRE) — Nexus Industrial REIT (the “REIT”) (TSX: NXR.UN) announced today its results for the quarter ended September 30, 2023. HighlightsNovember 1 – acquired a 336,448 square foot industrial property located in London, Ontario for $55.8 million with $27.1 million of the purchase price being settled in units valued at $11.30 per unit. September 12 – increased the REIT’s unsecured credit facilities from $375 million to $525 million. July 4 – acquired a 141,534 square foot industrial property located in Burlington, Ontario for $48.4 million. NOI from industrial properties anticipated to be approximately 91% for Q4 as a result of these transactions. Occupancy of 97% at September 30, 2023 was consistent with 97% at June 30, 2023 and September 30, 2022. Q3 2023 net operating income of $29.3 million...

Continue reading

Adial Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business Update

Advancing Discussions with Potential Strategic Partners Received Frost & Sullivan’s 2023 North American Precision Medicine for Addiction Disorders Technology Innovation Leadership Award Closed $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules; Extends Cash Runway into Q4 2024 CHARLOTTESVILLE, Va., Nov. 14, 2023 (GLOBE NEWSWIRE) — Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, today provided a business update and reported its financial results for the third quarter of 2023. Cary Claiborne, President and Chief Executive Officer of Adial, stated, “We have made steady progress throughout the third quarter of 2023 including receiving favorable...

Continue reading

Broad Capital Acquisition Corp Confirms Funding to Extend Period to Consummate Initial Business Combination to December 13, 2023

Dallas, Texas, Nov. 14, 2023 (GLOBE NEWSWIRE) — Broad Capital Acquisition Corp. (the “Company”) (NASDAQ: BRAC, BRACR, BRACU), a special purpose acquisition company formed by Broad Capital LLC, today announced that on November 10, 2023 it caused to be deposited $150,000 (the “Extension Payment”) into the Company’s trust account for its public stockholders, representing $0.0332 per public share, allowing the Company to extend the period of time it has to consummate its initial business combination to December 13, 2023 (the “Monthly Extension”). The Monthly Extension is the eleventh of the twelve monthly extensions permitted under the Company’s governing documents. Business Combination On January 18, 2023, the Company entered into a definitive Agreement and Plan of Merger and Business Combination Agreement (the “Business Combination...

Continue reading

Post Holdings Provides Additional Details Regarding the Fourth Quarter Fiscal 2023 Conference Call

ST. LOUIS, Nov. 14, 2023 (GLOBE NEWSWIRE) — Post Holdings, Inc. (NYSE: Post) (“Post”), a consumer packaged goods holding company, today provided additional details about its fourth quarter fiscal year 2023 earnings conference call. As previously announced, Post plans to release its financial results for the fourth quarter after market close on Thursday, November 16, 2023, and will hold a conference call on Friday, November 17, 2023 at 9:00 a.m. ET to discuss financial results for the fourth quarter and fiscal year 2023 and fiscal year 2024 outlook and to respond to questions. Jeff A. Zadoks, Executive Vice President and Chief Operating Officer, and interim President and Chief Executive Officer, and Matthew J. Mainer, Senior Vice President, Chief Financial Officer and Treasurer, will participate in the call. President and Chief...

Continue reading

Stantec to acquire ZETCON Engineering, a leading German infrastructure firm

EDMONTON, Alberta and NEW YORK and BOCHUM, Germany, Nov. 14, 2023 (GLOBE NEWSWIRE) — TSX, NYSE: STN Stantec, a global leader in sustainable design and engineering, has signed an agreement to acquire ZETCON Engineering, a 645-person engineering firm headquartered in Bochum, Germany. Founded in 1973, ZETCON has built a reputation as an industry leader in infrastructure planning, inspection, project management, and construction management. The terms of the transaction are not disclosed. The acquisition of ZETCON gives Stantec a strong platform focused on infrastructure. ZETCON has a total of 13 offices covering all major German metropolitan areas. The firm has extensive industry expertise in bridge certification and assessment, project and construction management of tunnels, roads, and rail infrastructure, as well as building condition...

Continue reading

Clairvest Reports Fiscal 2024 Second Quarter Results

TORONTO, Nov. 14, 2023 (GLOBE NEWSWIRE) — Clairvest Group Inc. (TSX: CVG) today reported results for the fiscal 2024 second quarter and six months ended September 30, 2023. (All figures are in Canadian dollars unless otherwise stated) HighlightsSeptember 30, 2023 book value was $1,181.0 million or $78.61 per share compared with $1,225.0 million or $81.54 per share as at June 30, 2023 Net loss for the quarter ended September 30, 2023 was $44.0 million or $2.93 per share Net loss for the six months ended September 30, 2023 was $24.5 million or $1.63 per share Clairvest and Clairvest Equity Partners VI (“CEP VI”) made an equity investment in Mountain Land Physical Therapy (“Mountain Land PT”) Clairvest and CEP VI invested in NexTech Solutions (“NexTech”) Clairvest and CEP VI completed the sale of Arrowhead Environmental Partners...

Continue reading

Avicanna Reports Q3 2023 Results

Acquisition of Medical Cannabis by Shoppers assets leading to the launch of MyMedi.ca.Record revenue of $6.27M, representing an increase of 90% over Q2, and 713% year-over-year.Improvements in performance including 46% consolidated gross margins and adjusted EBITDA of ($400k) TORONTO, Nov. 14, 2023 (GLOBE NEWSWIRE) — Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the commercialization of proprietary cannabinoid-based products and medical cannabis care platform is pleased to announce the results of Q3 2023. “We had the boldness to take on the challenge of acquiring the Medical Cannabis by Shoppers business and executed on integrating it into the newly developed MyMedi.ca to with a goal of being able to offer a comprehensive medical cannabis care platform and...

Continue reading

Dada Announces Unaudited Third Quarter 2023 Financial Results

SHANGHAI, China, Nov. 14, 2023 (GLOBE NEWSWIRE) — Dada Nexus Limited (NASDAQ: DADA, “Dada” or the “Company”), China’s leading local on-demand delivery and retail platform, today announced its unaudited financial results for the third quarter ended September 30, 2023. Third Quarter 2023 HighlightsTotal net revenues in the third quarter were RMB2,866.6 million, an increase of 20.4% year over year from RMB2,380.1 million in the same period of 2022. Total Gross Merchandise Volume (“GMV”) of JDDJ for the twelve months ended September 30, 2023 was RMB73.1 billion, an increase of 24.0% year over year from RMB58.9 billion in the same period of 2022.“We are delighted to report another quarter of robust growth and significant year-over-year margin improvement,” said Mr. Jeff He, President of Dada. “Along the path to achieving our mission...

Continue reading

CPI Aerostructures Reports Third Quarter and Nine Month 2023 Results

Third Quarter 2023 vs. Third Quarter 2022Revenue of $20.4 million compared to $20.2 million; Gross profit of $3.7 million compared to $5.3 million; Gross margin of 18.2% compared to 26.4%; Net income of $0.3 million compared to $1.9 million; Earnings per diluted share of $0.02 compared to $0.15; Cash flow from operations of $0.0 million compared to $2.9 million.Nine Months 2023 vs. Nine Months 2022Revenue of $63.0 million compared to $59.3 million; Gross profit of $13.0 million compared to $12.4 million; Gross margin of 20.6% compared to 21.0%; Net income of $2.4 million compared to $2.3 million ($3.1 million excluding first quarter severance accrual of $0.8 million); Earnings per diluted share of $0.19 compared to $0.19 ($0.25 excluding first quarter severance accrual of $0.06); Cash flow from operations of $0.8 million compared...

Continue reading

NKGen Biotech, Inc. Reports Third Quarter 2023 Financial Results and Business Highlights

– SNK01 Phase I autologous clinical program demonstrated improvement in neuroinflammation and cognitive function in patients with Alzheimer’s Disease, expect to initiate Phase I/IIa by year end – SNK02 Phase I allogeneic clinical program continues to progress; anticipated preliminary solid tumor data readout and IND filing for Parkinson’s Disease in 1Q24 SANTA ANA, Calif., Nov. 14, 2023 (GLOBE NEWSWIRE) — NKGen Biotech Inc. (Nasdaq: NKGN) (NKGen or the Company), a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous, allogeneic, and CAR-NK natural killer (NK) cell therapeutics, today announced its financial results for the third quarter ended September 30, 2023, and provided business highlights. “We had a very exciting quarter as a newly Nasdaq-listed company,” said Paul...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.